Back to results
US 2026/0091182 A1Published application
Metered dose inhalers of fluticasone or an ester thereof
AssigneeGlenmark Pharmaceuticals S.A.
InventorsJulianne BERRY, Rajesh ANKAM, Sushrut KULKARNI, Michael CRICK, Hemant PAWAR, Rajesh RAIKAR
Life of this patent
Estimating the term…
Abstract
The invention relates to metered dose inhaler comprising a stable pharmaceutical composition of fluticasone or its pharmaceutically acceptable ester contained in a canister fitted with a metering valve, an actuator and dose counter. The invention also relates to a process for preparing said pharmaceutical composition and its use in the treatment of respiratory disorders such as asthma in a subject (e.g., a human).
Claims14
1-11. (canceled)
A metered dose inhaler comprising:
- a pharmaceutical composition comprising:
- one of fluticasone or fluticasone ester;
- and
- one of a hydrofluoroalkane 227 propellant or a hydrofluoroalkane 134a propellant;
- a canister containing the pharmaceutical composition;
- a metering valve in fluid communication with the canister, the metering valve being configured to acquire a measured dose of the pharmaceutical composition from the canister, the metering valve comprising a valve stem defining a conduit;
- and
- an actuator configured to receive the measured dose from the metering valve and to deliver the measured dose, the actuator comprising:
- a valve stem block defining a sump, the sump having a volume of between 15 mm3 and 17 mm3, inclusive;
- a spray orifice having a diameter of between about 400 μm and about 700 μm;
- and
- a jet having a length of between about 1.40 mm and about 1.60 mm.
9 more elements
Dependencies are inferred from the claim text.